Brunswick Beats Q1 Estimates; Reiterates 2023 Guidance

Brunswick Corp (NYSE:BC) reported Q1 2023 sales growth of 3% year-on-year, to $1.74 billion, beating the consensus of $1.71 billion.…
  • Brunswick Corp (NYSE:BC) reported Q1 2023 sales growth of 3% year-on-year, to $1.74 billion, beating the consensus of $1.71 billion.
  • Segment Sales: Propulsion increased 7% Y/Y, Engine Parts and Accessories fell 13%, Navico Group was down 11% Y/Y and Boat climbed 17%.
  • Selling, general and administrative expenses rose 10% Y/Y to $211.3 million.
  • Adjusted operating margin was 15.0%, and adjusted operating income for the quarter fell 2% Y/Y to $262.4 million.
  • The company held $399.7 million in cash and marketable securities as of Q1 2023. Net cash used for operating activities of continuing operations was $(14.5) million.
  • Adjusted EPS of $2.57 beat the analyst consensus of $2.38.
  • The company repurchased shares worth $60 million and paid dividends of $28.5 million.
  • Outlook: Brunswick reiterated guidance for 2023 sales of $6.8 billion – $7.2 billion (vs. consensus of $6.98 billion) and adjusted EPS of $9.50 – $11.00 (vs. consensus of $10.27).
  • The company expects share repurchases of above $200 million in 2023.
  • It sees Q2 net sales flat to slightly up Y/Y and adjusted EPS of $2.60 – $2.70 (vs. consensus of $3.03).
  • Price Action: BC shares are trading lower by 0.61% at $82.57 on the last check Thursday.
Total
0
Shares
Related Posts
Read More

Cyclo Therapeutics, TRACON Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying

The Dow Jones dropped by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

CELZ